Dr. Jennifer Snyder received her B.S. in Microbiology from the University of Rochester and her Ph.D. in Microbiology and Immunology from the University of Maryland School of Medicine, where her research focus was in the field of bacterial pathogenesis. She joined the Center for Vaccine Development in 2005 and specializes in managing large multi-institution multi-project research programs. She is the Associate Director for the Middle Atlantic Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research Program (MARCE) and is PI of the MARCE Career Development and Training Program. She is also the Assistant Director of Research for the Cooperative Center for Translational Research on Human Immunology and Biodefense Program (CCHI).
Dr. Snyder specializes in research program management. Under the MARCE Program, her research interests include the development and testing of vaccines, diagnostics and therapeutics against emerging infectious diseases and agents of biowarfare. Her research interests under the CCHI program include studying the interplay of mucosal immunity, enteric vaccines, and microbiota in humans and in animal models.
Sinha P, Snyder JA, Kim EY, Moudgil KD. The major histocompatibility complex haplotypes dictate and the background genes fine-tune the dominant versus the cryptic response profile of a T cell determinant within a native antigen: relevance to disease susceptibility and vaccination. Scan. J. Immun. 2007; 65:158-65.
Snyder JA, Lloyd AL, Lockatell CV, Johnson DE, Mobley HLT. Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection. Infect Immun. 2006; 74:1387-93. PMCID: PMC1360342
Snyder JA, Haugen BJ, Lockatell CV, Maroncle N, Hagan EC, Johnson DE, Welch RA, Mobley HLT. Coordinate expression of fimbriae in uropathogenic Escherichia coli. Infect Immun. 2005; 73:7588-96. PMCID: PMC1273908
Snyder JA, Haugen BJ, Buckles EL, Lockatell CV, Johnson DE, Donnenberg MS, Welch RA, Mobley HLT. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun. 2004; 72:6373-81. PMCID: PMC523057
Griswold AR, Chen YM, Snyder JA, Burne RA. Characterization of the arginine deiminase operon of Streptococcus rattus FA-1. Appl Environ Microbiol. 2004; 70:1321-7. PMCID: PMC368411
Dong Y, Chen YY, Snyder JA, Burne RA. Isolation and molecular analysis of the gene cluster for the arginine deiminase system from Streptococcus gordonii DL1. Appl Environ Microbiol. 2002; 68:5549-53. PMCID: PMC129940
Gunther NW, Snyder JA, Lockatell V, Blomfield I, Johnson DE, Mobley HLT. Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or off. Infect Immun. 2002; 70:3344-54. PMCID: PMC128061
Chen YY, Betzenhauser MJ, Snyder JA, Burne RA. Pathways for lactose/galactose catabolism by Streptococcus salivarius. FEMS Microbiol Lett. 2002; 209:75-9.